Total Clarity Wealth Management, Inc. Phio Pharmaceuticals Corp. Transaction History

Total Clarity Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$0.99 - $1.99 $1,485 - $2,985	-1,500 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$1.62 - $2.28 $2,430 - $3,419	1,500 New	1,500 $3,000
Q2 2021 Jul 26, 2021	SELL	$1.87 - $2.8 $2,805 - $4,200	-1,500 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$2.48 - $4.05 $3,720 - $6,075	1,500 New	1,500 $4,000

Ticker PHIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,658,700
Market Cap $30.2M
Description
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.